Nature research paper: Selective haematological cancer eradication with preserved haematopoiesis go.nature.com/4aBDWmC

Thank you Genetic Engineering & Biotechnology News for a nice and clear overview article about our work

Thanks @Jeff_Mold. It is still at times worth going to conferences 🙂

Thanks @AngelikaJacobs for writing this

Simon Garaudé JekerLab New Media Center Cimeio Therapeutics Great to see that Simon Garaudé’s research has recently been published in nature. Here is a fascinating summary by Simon himself in which he explains how the team selectively eradicated haematological cancers, preserving healthy haematopoiesis and thus cornering cancer cells. 🧵👇

Exactly, and, actually Marc, we previously used CD45.2 and CD45.1 (and CD90.2 and CD90.1) to convince ourselves that this will work in humans: journals.aai.org/jimmunol/artic…

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Another scientist whose work initially didn't get the recognition that it deserved - Victor Ambros was denied tenure at Harvard, even after publishing the seminal work that resulted in him receiving the Nobel Prize today!

*Efficient PAMless base editing in patient-derived HSPCs* 🧬🖌️ science.org/doi/10.1126/sc… For a few years now, we've been collaborating with clinical experts to develop genome editing-based treatments for genetic diseases. It has been a great fortune to work with, and learn from,

#CRISPR cures on-demand can and will be scaled nationwide. In this talk at the Oxford-Harrington symposium I argue - with data - that the first nation to do so will be the United Kingdom and describe an actionable path to that goal. youtu.be/qlzhcYh7cLM?si…

Never could I have imagined that ABE would someday enable such a transformative outcome for a child. Thank you Kiran Musunuru, Rebecca Ahrens-Nicklas, and KJ’s family for having the courage to demonstrate to the world what is possible. Incredible. 💕 nytimes.com/2025/05/15/hea… via

We're thrilled to be organizing a CRISPR-Cas9 workshop in the beautiful city of Sorrento, featuring renowned scientists from around the globe! meetings.embo.org/event/25-crisp…

LIVE NOW: FDA's Cell and Gene Therapy Roundtable Captions available here: bit.ly/4dQaNaz x.com/i/broadcasts/1…

There's still time to register for the CRISPR-Cas9 workshop - registration has been extended. Participate to the second CRISPR-Cas9 workshop in the beautiful city of Sorrento, featuring renowned scientists from around the globe! meetings.embo.org/event/25-crisp…

To me, this is the most remarkable thing about global health: With a relatively small amount of money, you can do a great deal of good for a great many people. This is money well spent, and we should go back to spending it—now.

We mourn the loss of our beloved department member, Prof. Zelig Eshhar — a visionary immunologist and pioneer of CAR-T cell therapy. His groundbreaking work revolutionized cancer treatment and gave hope to countless patients.

Very promising news on the next seven-year EU budget, with a proposed substantial increase for Horizon Europe including the ERC. We are analysing the other parts of this proposal in more detail. @Vonderleyen Ekaterina Zaharieva research-and-innovation.ec.europa.eu/news/all-resea…

Data from the second human treated with a prime edited medicine: a 56-year-old male with chronic granulotamous disease (CGD) had his bone marrow prime edited to insert the missing GT in NCF1, restoring NADPH oxidase function in neutrophils (DHR positivity) several fold beyond the

We discovered that the skull bone marrow has direct connections to brain surface & mirrors brain inflammation, making it a new site for diagnosing & monitoring brain pathologies. Kolabas…Ertürk, Cell: cell.com/cell/pdf/S0092… biorxiv.org/content/10.110… bit.ly/3PQuymm

Very important comments from Noubar Afeyan! He’s 💯 right!